Advancing predictive oncology: Integrating clinical and radiomic models to optimize transarterial chemoembolization outcomes in hepatocellular carcinoma.
1/5 보강
This article discusses the innovative use of computed tomography radiomics combined with clinical factors to predict treatment response to first-line transarterial chemoembolization in hepatocellular
APA
Baddam S (2025). Advancing predictive oncology: Integrating clinical and radiomic models to optimize transarterial chemoembolization outcomes in hepatocellular carcinoma.. World journal of clinical cases, 13(28), 109397. https://doi.org/10.12998/wjcc.v13.i28.109397
MLA
Baddam S. "Advancing predictive oncology: Integrating clinical and radiomic models to optimize transarterial chemoembolization outcomes in hepatocellular carcinoma.." World journal of clinical cases, vol. 13, no. 28, 2025, pp. 109397.
PMID
40881015 ↗
Abstract 한글 요약
This article discusses the innovative use of computed tomography radiomics combined with clinical factors to predict treatment response to first-line transarterial chemoembolization in hepatocellular carcinoma. Zhao developed a robust predictive model demonstrating high accuracy (area under the curve 0.92 in the training cohort) by integrating venous phase radiomic features with alpha-fetoprotein levels. This noninvasive approach enables early identification of patients unlikely to benefit from transarterial chemoembolization, allowing a timely transition to alternative therapies such as targeted agents or immunotherapy. Such precision strategies may improve clinical outcomes, optimize resource utilization, and increase survival in advanced hepatocellular carcinoma management. Future studies should emphasize external validation and broader clinical adoption.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Raman Spectroscopic Signatures of Hepatic Carcinoma: Progress and Future Prospect.
- Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025).
- Heat Shock Protein 47 as a Novel Predictive and Diagnostic Biomarker for Thrombosis in Hepatocellular Carcinoma.
- Crosstalk Between -Regulatory Elements and Metabolism Reprogramming in Hepatocellular Carcinoma.
- Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study.